Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20884247 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated
Has Results
Sandostatin for Patients With Androgen Independent Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: Sandostatin

Indicates status has not been verified in more than two years